Samantha Pearce Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

JAZZ Quotes by TradingView

Samantha Pearce is EVP, Chief Commercial Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 24,078 shares of JAZZ, which is worth approximately $3 Million. The most recent transaction as insider was on Mar 05, 2022, when has been sold 1,836 shares (Ordinary Shares) at a price of $153.96 per share, resulting in proceeds of $282,671. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.1K
0% 3M change
82.98% 12M change
Total Value Held $3 Million

Samantha Pearce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2022
SELL
Payment of exercise price or tax liability
$282,671 $153.96 p/Share
1,836 Reduced 11.62%
13,961 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
3,839 Added 19.55%
15,797 Ordinary Shares
Mar 05 2021
SELL
Payment of exercise price or tax liability
$230,980 $164.75 p/Share
1,402 Reduced 10.49%
11,958 Ordinary Shares
Feb 25 2021
BUY
Grant, award, or other acquisition
-
3,160 Added 19.13%
13,360 Ordinary Shares
SP

Samantha Pearce

EVP, Chief Commercial Officer
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JAZZ